Table 1

Patient and tumour characteristics

MPM
(n=11 539)
MPeM
(n=629)
Total
(N=12 168)
P value
Age, median (IQR)71 (64–77)69 (61–76)71 (64–77)0.004
Male, n (%)10 085 (87.4)458 (72.3)10 543 (86.6)<0.001
Histology, n (%)*
 Epithelioid6061 (76.2)368 (88)6429 (76.8)<0.001*
 Sarcomatoid1149 (14.5)18 (4.3)1167 (13.9)
 Biphasic739 (9.3)32 (7.7)771 (9.2)
 Unknown35902113801
Side, n (%)*
 Left4499 (40.4)
 Right6631 (59.6)
 Unknown409
Stage (TNM), n (%)*
 I2840 (37.2)
 II918 (12)
 III1971 (25.8)
 IV1897 (24.9)
 Unknown3913
Stage (EOD), n (%)*
 1. In situ0
 2. Local disease190 (40.8)
 3. Contiguous/invasive123 (26.4)
 4. Regional lymph nodes22 (4.7)
 5. Regional progression12 (2.6)
 6. Distant progression119 (25.5)
 Unknown163
Metastases, n (%)†610 (10.6)54 (18.6)664 (11)<0.001
 Multiple metastatic sites149 (2.6)11 (3.8)160 (2.6)0.021
Most common metastatic sites, n (%)†
 Lung163 (2.8)7 (2.4)170 (2.8)
 Lymph node159 (2.8)11 (3.8)170 (2.8)
 Bone135 (2.3)135 (2.2)
 Liver73 (1.3)13 (4.5)86 (1.4)
 Peritoneum79 (1.4)5 (1.7)84 (1.4)
 Soft tissue59 (1)3 (1)62 (1)
 Adrenal glands52 (0.9)1 (0.3)53 (0.9)
 Pleura12 (0.2)15 (5.2)27 (0.4)
 Cutaneous12 (0.2)12 (0.2)
 Brain15 (0.3)15 (0.2)
  • *Percentage and p value based on known cases.

  • †Metastases were registered nationwide from 2008 onwards; percentages based on 6038 cases (MPM n=5757, MPeM n=291).

  • EOD, Extent of Disease classification; MPeM, malignant peritoneal mesothelioma; MPM, malignant pleural mesothelioma; TNM, tumour, node, metastases classification.